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The superficial femoral-popliteal vein (SFPV) is
now well established as a reliable alternative conduit
in aortoiliac,1-3 infrainguinal,4-6 and major venous7
reconstructions. Fears of excessive acute and chron-
ic venous hypertension leading to significant mor-
bidity and possible limb loss as a consequence of
SFPV removal persist.8 However, other authors have
documented surprisingly few problems on late clini-
cal follow-up.9 We previously reported a low inci-
dence of early venous morbidity associated with
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Purpose: The superficial femoral-popliteal vein (SFPV) is a reliable conduit for aortoili-
ac, infrainguinal, and venous reconstructions. In this prospective study, we characterized
the anatomic and physiologic changes in SFPV harvest limbs and their relationship to
the development of late venous complications. 
Methods: Since 1990, we have studied 61 patients after harvest of 86 SFPVs at 6-month
intervals with clinical examinations, lower-extremity venous duplex, and venous func-
tion tests. The CEAP system was used as a means of categorizing clinical changes. 
Results: Mean (± SEM) follow-up was 37 ± 3 months. Less than one third of harvest
limbs had edema without skin changes (C3). No patient had major chronic venous
changes (C4 to C6) or venous claudication. There were no significant differences in limb
measurements between harvest and non-harvest limbs, except in a subgroup of patients
with unilateral harvest in which there was a small but significant (P = .046) increase in
harvest limb thigh and calf circumference, compared with the opposite non-harvest
limb. These clinical results were not affected by the presence or absence of an intact
greater saphenous vein (GSV). Large, direct collaterals (4 to 6 mm in diameter) between
the popliteal vein stump and profunda femoris vein (PFV) were seen by means of duplex
ultrasonography in 29 harvest limbs (34%). The remainder appeared to have smaller, less
direct collaterals to the PFV. Mild venous reflux with rapid cuff deflation was present at
the popliteal or posterior tibial vein in nine of 79 harvest limbs (11%). Six of these nine
limbs (67%) with reflux were clinical class C3, compared with only 19 of the 70 limbs
without reflux (27%; P = .02). Ambulatory venous pressure (AVP) with exercise was sig-
nificantly increased in harvest limbs (60 ± 4.7 mm Hg), compared with non-harvest
limbs (47.8 ± 5.2 mm Hg; P = .049). The AVP recovery time of harvest limbs (14.0 ±
1.0 seconds) was reduced, compared with non-harvest limbs (23.5 ± 4.5 seconds; P =
.02). AVPs (exercise) remained stable or decreased in six of 10 harvest limbs measured
serially. Venous refill time in harvest limbs (15.1 ± 1.1 seconds) was shortened, com-
pared with non-harvest limbs (22.3 ± 2.1 seconds)(P = .002). Venous outflow obstruc-
tion measured by means of plethysmography was present in 93% of harvest limbs, com-
pared with 36% of non-harvest limbs (P = .001).
Conclusion: SFPV harvest results in minimal mid-term to late-term lower-extremity
venous morbidity despite outflow obstruction. The most likely mechanisms preserving
clinical status include the low incidence of mild reflux, the presence of collateral venous
channels, and the lack of progression in abnormal harvest limb physiology. The absence
of the ipsilateral GSV does not adversely affect clinical outcome. (J Vasc Surg
1999;29:282-91.)
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SFPV harvest,1,3 but careful long-term follow-up of
the donor limbs, with specific attention to alter-
ations in venous physiology and relationship to late
venous morbidity, was not available. We hypothe-
sized that SFPV removal does not lead to chronic
venous morbidity and remains a safe procedure. We
reviewed prospectively collected data to characterize
the mid-term to late-term anatomic and physiologic
changes in harvest limbs and their relationship to the
development of late venous complications. 
METHODS
Sixty-one patients undergoing arterial and
venous reconstructions with 86 SFPVs since 1990
were studied. In most cases, the vein was harvested
from its junction with the profunda femoris vein
(PFV) down to or below the knee. These patients
have been studied prospectively at 6-month intervals
with clinical examinations, lower-extremity venous
duplex ultrasound, venous function tests, and ankle-
brachial indices (ABI). Clinical symptoms in the har-
vest and non-harvest limbs were studied and catego-
rized according to the CEAP system for classifica-
tion of chronic lower-extremity venous disease.10
Attention was also directed to differences between
SFPV harvest limbs in which the greater saphenous
vein (GSV) was intact and those in which it was
absent. Measurements of leg circumference were
obtained at the thigh (14 cm above the knee joint),
proximal and midcalf (3 cm and 10 cm below the
anterior tibial tuberosity), and ankle.
Venous duplex ultrasound examination was con-
ducted with the patient recumbent by means of a
5.0 MHZ probe (Acuson 128XP/10v, Mountain
View, Calif). Preoperative examinations were per-
formed to assess size and quality of the SFPVs and
saphenous system. Postoperative studies included
qualitative assessment of flow and reflux in the
saphenous and deep veins, including the common
femoral vein (CFV), PFV, SFPV when present, and
posterior tibial veins. The diameters of intact GSVs
were measured at midthigh. The presence and
extent of venous thrombosis was noted, and venous
collateral pathways were identified.
Venous reflux was measured using the quantita-
tive rapid cuff deflation duplex technique described
by van Bemmelen et al.11 With the patient standing,
a rapid cuff inflator (Hokanson E20/AG101,
Bellevue, Wash) was placed at varying levels on the
non–weight-bearing limb and inflated for 3 seconds
to a pressure exceeding estimated hydrostatic pres-
sure (80 to 120 mm Hg). After rapid (less than 0.3
seconds) deflation, reversal of venous flow was
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detected by means of duplex ultrasound in the
venous segment proximal to the cuff. The cuff was
placed at the thigh, calf, and foot to obtain mea-
surements at the CFV, PFV, superficial femoral vein,
popliteal vein, and posterior tibial veins. Abnormal
reflux was defined as reversal of flow persisting for
longer than 0.5 seconds. 
Late in the study, ambulatory venous pressures
(AVP), venous refill time (VRT), and venous outflow
obstruction were measured to specifically correlate
AVPs with obstructive patterns and venous reflux
patterns in the harvest limbs. AVP measurements, as
described by Kriessmann12 and Nicolaides et al,13
provide a quantitative, overall measure of lower-
extremity venous function. Pressure measurements
were obtained at rest and during exercise (10 to 20
tiptoe movements at a rate of one per second) after
cannulation of a superficial foot vein with a 20-gauge
catheter. The catheter was connected to a Uniflow dis-
posable pressure transducer (Baxter Healthcare
Corporation, Irvine, Calif) and acquisition unit and
monitor (Marquette, Milwaukee, Wis). Measurements
were made in both SFPV harvest and non-harvest
limbs. Serial measurements were made in 10 limbs. In
addition to measurement of pressure before, during,
and after exercise, the time for venous pressure to
return to baseline (recovery time) after exercise was
recorded. Normal resting and exercise pressures are
90 ± 10 mm Hg and 30 ± 10 mm Hg. Normal recov-
ery time is 17 ± 6 seconds.12
VRT, derived by means of photoplethysmogra-
phy (Medacord PVL, Medasonics, Fremont, Calif),
was also measured. Measurements were made with
the patient in a sitting position, legs hanging freely.
The phototransducer was placed on the anteromedi-
al aspect of the lower leg above the medial malleo-
lus. Recordings were made after five foot flexion-
extensions, with and without a below-knee cuff.
Normal VRT in our laboratory is 18 to 23 seconds.
Venous outflow obstruction was assessed by
means of strain gauge plethysmography (Medacord
PVL). The patient was positioned supine, with the
heel resting on a support and the leg externally rotat-
ed and slightly flexed. A 33-cm strain gauge was
placed around the largest circumference of the calf.
Venous capacitance was measured in a 2-minute peri-
od after inflation of a thigh cuff to 60 mm Hg.
Venous outflow was measured during the 3 seconds
after deflation of the thigh cuff. A venous outflow vs
venous capacitance discriminant line chart was used as
a means of plotting results as normal or abnormal.26
Statistics. Continuous data are expressed as
mean ± SEM. Paired and unpaired t tests were used
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to examine differences between groups when applic-
able. The chi-square test was used for proportional
data. Results were considered statistically significant
at a P value less than .05.
RESULTS
Of the 61 patients studied, 41 were men and 20
were women. The average age was 58 ± 2 years
(range, 18 to 80 years). The mean follow-up period
was 37 ± 3 months. Demographic data about co-
morbid conditions and cardiovascular risk factors
were reported previously.1 Thirty-six patients (59%)
underwent aortoiliac/femoral reconstruction, 10
(16%) infrainguinal bypass or femoral crossover,
seven (11%) carotid or upper-extremity reconstruc-
tions, five (8%) renal or mesenteric revasculariza-
tions, and three (5%) venous bypass procedures,
none of which were lower-extremity reconstruc-
tions. One patient had preexisting venous disease
with lower-extremity varicose veins; however, no
patients had ulceration. Two patients had a previous
history of deep venous thrombosis (DVT), one of
whom had mild unilateral edema. Subcutaneous
heparin and pneumatic compression devices were
used perioperatively for DVT prophylaxis.
There were 120 limbs studied in 61 patients
(two limbs had been amputated). Eighty-six SFPVs
were harvested. Twenty-five patients had bilateral
SFPV removal, and 36 had single limb vein harvest,
leaving 34 non-harvest limbs. Among the harvest
limbs, 57 had an intact greater saphenous system, 20
had earlier GSV removal, and nine had concomitant
SFPV and GSV harvest.
More than two thirds of the limbs were free of
symptomatic venous disease (C0), and there was no
difference between limbs with and without an intact
GSV (C0 = 65% and 69%, respectively)(Table I).
These groups did not differ significantly from non-
harvest limbs. No patients had major chronic venous
changes (C4 to C6) or venous claudication. Less than
one third of harvest limbs had edema without skin
changes (C3), and there was no increase in the fre-
quency of this finding in the group of patients with-
out the GSV. In addition, there was no relationship
between the extent of the vein harvested and the
presence of edema. Three patients had transient,
early edema without skin changes that resolved with-
in 30 days. Three patients that had preexisting limb
edema were not affected by SFPV harvest. 
Serial limb measurements were performed in
every patient (n = 29) during the first 2 years of study
(Table II). These measurements were discontinued in
subsequent patients because of the lack of clinically
significant swelling and stable clinical venous scores.
There were no significant differences in limb mea-
surements between non-harvest limbs, harvest limbs
with and without GSV, and harvest limbs that were
clinical class C3. However, in a subgroup of 14
patients with unilateral SFPV harvest, there was a
small but significant increase in harvest compared
with non-harvest limb circumference at the thigh (1.7
± 0.7 cm, P = .02), proximal calf (1.1 ± 0.5 cm, P =
.04), and distal calf (2.0 ± 0.4 cm, P = 0.047). There
was no increase in ankle size in this subgroup. Eight
patients (13%) wore graded compression stockings
more than 6 months after operation.
Postoperative DVT was observed in 19 harvest
limbs (22%) within 1 week of operation. In 16 of
these 19 (84%), the DVT was confined to the
popliteal vein stump, without significant extension
into calf veins. Resolution was documented in two of
these limbs on subsequent examinations. None of
these patients were treated with anticoagulants.
Thirty-one percent of these limbs were clinical class
C3, which is not statistically different from the group
as a whole. Three patients had proximal DVT. One
had occlusion of the PFV, one had a nonocclusive
thrombus in the CFV, and the third had nonocclusive
thrombus in both the PFV and CFV. All three
patients were treated with anticoagulants. Two of
these patients were clinical class C3. 
By means of the immediate postoperative and
the serial follow-up duplex ultrasonography, flow
through direct 4 to 6 mm diameter connections
between the popliteal vein stump and PFV was seen
in 29 harvest limbs (34%; 21 patients; Fig 1). The
remaining 57 harvest limbs appeared to have small-
er, less direct collaterals to the PFV. Flow through
ipsilateral GSVs was increased and continuous in 15
of 57 (26%) of the harvest limbs with GSV present.
In addition, these GSVs increased in size postopera-
tively (preoperative diameter, 4.08 ± 0.05 mm, vs
postoperative diameter, 4.73 ± 0.2 mm; P = .004).
Table I. Clinical classification of superficial
femoral-popliteal vein harvest limbs with and with-
out greater saphenous vein (GSV) present
Non-harvest Harvest limbs Harvest limbs
limbs with GSV with GSV
Classification (n = 34) present (n = 57) absent (n = 29)
C0 26 (76%) 37 (65%) 20 (69%)
C1 0 0 0
C2 0 2 (3%) 0
C3 8 (24%) 18 (32%) 9 (31%)
C4-6 0 0 0
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The increase in GSV size was apparent by means of
the first postoperative duplex examination that was
performed within days of SFPV harvest and persist-
ed. None of these changes were present in non-har-
vest limbs. The distribution of clinical class of the
limbs with direct connections to the PFV was very
similar to that of the harvest limb group as a whole.
Twenty-eight percent of these patients were C3.
However, among the 15 limbs with increased flow in
the saphenous system, only two (13%) were classi-
fied as C3.
Seventy-nine harvest limbs had duplex-derived
venous reflux testing. Five patients (seven limbs) did
not have this testing because of technically inade-
quate studies and patient inability to stand on one
leg and support themselves on a walker. Reflux was
present in nine of 79 harvest limbs (11%) and 13% of
patients studied. In all nine limbs, the site of reflux
was the popliteal or posterior tibial veins. The dura-
tion of reflux ranged from 0.5 to 1.5 seconds. Six of
the nine limbs with reflux (67%) were clinical class
C3, compared with 19 of the 70 limbs without reflux
(27%; P = .02). Only three of these limbs (33%) had
popliteal vein thrombus visualized by means of
immediate postoperative duplex studies. Pathologic
reflux was not present in harvest limb GSVs (n = 57)
or in non-harvest limbs (n = 31).
Physiologic testing (AVPs, VRT, strain gauge
plethysmography) was initiated later in the study and
completed in 28 patients (46%). Twenty-four
patients (42 limbs) underwent AVP measurement.
Reasons for incomplete AVP measurements includ-
ed patient refusal, inability to cannulate small foot
veins, and “blown” veins during study. VRT and
venous outflow measurements were performed in all
28 patients (54 limbs). Despite these shortcomings
in AVP measurements, 42 limbs had all three func-
tional tests performed, allowing meaningful exami-
nation of this cohort. There was no difference in
clinical status between those patients who under-
went this testing and those who did not.
AVPs were obtained in 42 limbs, including 28
harvest limbs and 14 non-harvest limbs (Table III).
Initial studies were performed a mean of 11 ± 2
months after operation (range, 1 to 46 months).
AVP (exercise) was significantly increased in harvest
limbs, compared with non-harvest limbs (P = .048),
and this was most apparent in limbs with GSV pre-
sent. Elevation to pathologic levels (more than 80
mm Hg) was identified in only two harvest limbs
(7%; two patients, 8%) in which AVPs were mea-
sured. The AVP recovery time of harvest limbs was
reduced by half that of non-harvest limbs (P = .02).
The AVP (exercise) in C3 limbs of 71.0 ± 2.5 was
significantly elevated, compared with 53.3 ± 5.8 in
C0 limbs (P = .01).
Ten harvest limbs underwent serial AVP mea-
surements within a mean of 19 ± 4 months (Fig 2).
Four of the 10 limbs showed a mild elevation in
exercise pressure with time, with the mean increase
being 9 ± 2.5 mm Hg.
Venous refill time in harvest limbs (n = 40) of
15.1 ± 1.1 seconds was significantly shortened, com-
pared with a refill time of 22.3 ± 2.1 (P = .002) in
non-harvest limbs (n = 14). Measurements with a
below-knee cuff in place were almost identical. The
Fig 1. Popliteal vein stump to profunda femoris vein collateral.
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presence or absence of an ipsilateral GSV made no
difference in these measurements. 
Significant venous outflow obstruction, mea-
sured by means of strain gauge plethysmography,
was present in 37 of 40 harvest limbs (93%), com-
pared with 5 of 14 non-harvest limbs (36%; P =
.001). Results are shown in Fig 3. Again, the pres-
ence or absence of ipsilateral GSV did not apprecia-
bly affect these results.
Arterial circulation in the harvest limbs, as esti-
mated by the ABI, was not different between the
clinical groups. The mean ABI among those in class
C0 was 0.87 ± 0.03, in class C2 was 0.67 ± 0.04, and
in class C3 was 0.89 ± 0.03.
DISCUSSION
Superficial femoral vein ligation as prophylaxis
against pulmonary embolism in extremities with
DVT is associated with no significant venous mor-
bidity on long-term follow-up.14 Schanzer et al9
reported on harvest leg status in 25 limbs after SFPV
removal for use as femoral-popliteal bypass grafts.
They found that harvest limbs had an average calf
circumference only 1.4 ± 1.8 (SD) cm greater than
the opposite non-harvest limb. There were no sig-
nificant symptoms of venous insufficiency in a 3-year
follow-up. Other investigators,2,4 in reports describ-
ing the use of SFPV for arterial reconstructions,
recorded chronic limb edema in only 7% to 20% of
patients. Our findings confirm that clinical venous
morbidity in donor limbs after SFPV removal is min-
imal at 37 months follow-up. Evidence of chronic
venous insufficiency developed in only one third of
our patients; no patients had uncontrollable edema,
skin pigment changes, lipodermatosclerosis, venous
claudication, or venous ulceration. The only clinical
manifestation of venous disease in our cohort was
mild lower-extremity edema (n = 27) and superficial
varicosities (n = 2). Swelling occurred shortly after
SFPV harvest and persisted on long-term follow-up.
Only 13% of all patients required long-term com-
pression stockings. Patients studied longitudinally
within a mean of 37 months did not experience clin-
ical deterioration, as evident by means of changes in
CEAP classification. 
Few have examined the late anatomic changes
that may develop after the removal of the major
venous outflow tract of the leg. Cadaver studies have
shown that an extensive system of veins provide com-
munication between the distal superficial femoral and
popliteal vein and the profunda femoral vein.15 Raju
and Fredericks16 studied 137 limbs with deep venous
obstruction. They noted that a collateral vessel con-
necting the profunda femoris system with the
popliteal vein was present in all cases of femoral vein
obstruction. They refer to the development of this
collateral as “axial transformation” of the PFV.
Similarly, Masuda and colleagues14 described several
patterns of collateral flow seen by means of color flow
duplex examination, including the development of
Table II. Limb circumference measurements (cm ± SEM)
Non-harvest Harvest limbs Harvest limbs C3 harvest 
limbs (n = 14) with GSV (n = 29) without GSV (n = 13) limbs (n = 17)
Thigh 41.9 ± 1.7 38.7 ± 1.0 42.0 ± 1.8 41.9 ± 1.3
Proximal calf 32.4 ± 0.9 33.0 ± 0.6 32.9 ± 1.2 34.9 ± 0.9
Midcalf 33.7 ± 1.4 33.6 ± 1.0 34.4 ± 1.9 37.5 ± 1.3
Ankle 23.6 ± 0.6 24.0 ± 0.5 24.4 ± 0.9 23.6 ± 0.5
GSV, Greater saphenous vein.
Table III. Ambulatory venous pressure results
Non-harvest Harvest limbs Harvest limbs 
limbs (n = 14) with GSV (n = 20) without GSV (n = 8) P value
AVP rest (mm Hg) 77.9 ± 5.3 82.4 ± 5.1 77.8 ± 4.9 NS
AVP exercise (mm Hg) 47.8 ± 5.2 60.0 ± 4.7 58.7 ± 7.5 .048*
Change with exercise (mm Hg) 30.0 ± 6.1 23.0 ± 4.1 28.3 ± 6.8 NS
Change with exercise (%) 34.0 ± 6.0 29.4 ± 5.0 33.5 ± 8.6 NS
AVP recovery time (seconds) 23.5 ± 4.5 13.8 ± 1.2 14.6 ± 1.7 .02†
GSV, Greater saphenous vein; AVP, ambulatory venous pressure.
*Non-harvest vs. harvest limbs with GSV.
†Non-harvest vs. harvest limbs with and without GSV.
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major collaterals with the PFVs after superficial
femoral vein ligation. By means of color flow duplex
survey, a large (more than 4 mm in diameter) con-
nection between the popliteal vein and PFV was seen
in 34% of our SFPV harvest limbs. Smaller commu-
nicating vessels were clearly visualized in the remain-
der. In addition, in 26% of patients with an intact
GSV in the donor limb, vein size and flow on venous
duplex examination appeared to be increased. Flow
in these veins was continuous, lacking the normal
phasic variations expected within the GSV.
Physiologic studies noted significant ambulatory
venous hypertension with exercise in most patients,
measured by means of direct pedal vein puncture.
Abnormalities in strain-gauge venous plethysmogra-
phy suggested that venous outflow obstruction is an
immediate consequence of SFPV removal. Elevated
AVP (exercise), shortened AVP recovery times, and
photoplethysmographic venous refill times were pre-
sent in most patients. These changes could be caused
by an obstructive component to venous outflow,
venous valvular incompetence in the remaining seg-
ments, or a combination of both. However, with the
addition of duplex-measured valve closure time with
rapid cuff deflation, most limbs retained competent
popliteal, tibial, and profunda femoral vein valves.
The presence of valvular competence combined with
elevated ambulatory venous pressures, shortened AVP
recovery times, and venous refill times suggests that
most ambulatory venous hypertension seen in these
harvest limbs is obstructive in nature. These findings
are consistent with those of other investigators.2,5,9,14
In addition, the presence of an intact GSV had no sig-
nificant influence on the severity of venous hyperten-
sion in the harvest limbs.
The presence of obstructive physiology, however,
does not appear to correlate with the clinical status of
SFPV harvest limbs. Studies of the pathogenesis and
hemodynamics of clinically significant chronic venous
disease implicate other contributing factors, including
venous valvular insufficiency, ineffective calf muscle
pump function,17 and increased arterial inflow.18 Of
these factors, valvular insufficiency or reflux appears to
be the most significant. Numerous authors19-24 have
shown that reflux is almost universally present in
patients with skin changes and ulceration and that the
degree of reflux directly correlates with the severity of
symptoms. In the present study, mild reflux limited to
Fig 2. Serial ambulatory venous pressure measurements in 10 harvest limbs.
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the popliteal venous segment was evident in only 11%
of SFPV harvest limbs. Patients with class C3 venous
changes had significantly more popliteal venous
incompetence than patients without clinical changes.
Valvular incompetence appeared to be the only find-
ing distinguishing those patients with more severe
clinical venous disease from those without clinical
sequelae. All others had equally severe physiologic
venous hypertension caused by obstructed venous
outflow. We suspect that valvular competence in our
patients is a protective mechanism with regard to
development of more severe clinical venous changes.
However, even in the absence of competent popliteal
valves, more severe C4-6 clinical disease has not devel-
oped in any patients.
The impact of DVT in the retained popliteal seg-
ment on valvular competence is uncertain. Only three
limbs with popliteal DVT had late evidence of valvu-
lar incompetence. The other 13 harvest limbs with
DVT did not have late evidence of incompetent
popliteal valves. Limbs with popliteal DVT had no
additional venous morbidity, compared with limbs
without DVT. We suspect, based on these data, that
the development of popliteal DVT in the retained
venous stump is of little clinical consequence. Because
of significant bleeding risk in many of these patients
after extensive operations and the minimal embolic
risk after SFPV removal, we continue to observe and
withhold anticoagulation in these patients.
We recognize that a mean follow-up time of 3
years may be insufficient to conclude that significant
venous morbidity will not occur. The elevation of
AVP (exercise) despite collateral blood flow and
competent valve mechanisms reflects an underlying
obstructive physiology in these limbs. Although not
progressive in most cases, this elevation may manifest
clinically at some later time. In a review of 220
patients with venous disease, Nicolaides et al25
showed that the incidence of ulceration in patients
with AVP in the range of 51 to 60 mm Hg was
almost 40%. The duration of ambulatory venous
hypertension in these patients with ulceration is
uncertain. It is somewhat reassuring that our patients
have not shown any signs of deterioration in clinical
status with follow-up as long as 8 years.
SFPV harvest results in minimal lower-extremity
venous morbidity despite physiologic evidence of
outflow obstruction. Infrequent and mild reflux,
Fig 3. Venous outflow and venous capacitance discriminant line chart.
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collateral venous channels, and a lack of progression
in abnormal harvest limb physiology are important
mechanisms in preserving clinical status. The
absence of ipsilateral GSV does not adversely affect
clinical outcome.
We thank Eva A. Scoggins, RT, RVT, and John T.
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Dr Harry R. Schanzer (New York, NY). The use of
the superficial femoral-popliteal vein as an autogenous
arterial bypass for infrainguinal revascularization was
introduced by Martin Schulman in 1981. He reported
excellent results, with patency rates above 70% at 3 years
and minimal venous morbidity. After his pioneering work,
others reported similar good results using this deep vein as
an arterial substitute in carotid and aortoiliac position and
as a venous substitute for large veins, such as the vena cava
and portal vein. 
In spite of these positive reports, skepticism on the use
of deep veins persists, fed by the fear that their removal
will result in severe venous outflow obstruction of the
donor leg. To determine if this concern is justified, Dr
Clagett’s group performed a detailed clinical ultrasono-
graphic and plethysmographic study of 86 extremities that
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served as donors for superficial femoral-popliteal veins.
They demonstrated that 90% of the limbs had functional
obstruction. Also, occasional mild reflux was found in
these extremities. In spite of these functional abnormali-
ties, clinically there was minimal venous morbidity. Less
than one third of the limbs had mild edema without fur-
ther pathological changes at 3 years of mean follow-up.
These findings are almost identical to the ones published
by us in 1991. 
This a very important paper. It presents further
irrefutable data demonstrating the safety of using the
superficial femoral-popliteal vein as a bypass conduit. 
I have two questions for Dr Wells. 
First, from your manuscript I have learned that you
used deep veins in patients that have had earlier deep
venous thrombosis. Is there any situation in which you
would refrain from using these veins? 
Second, there has been a relatively recent report in the
literature from Dr Coburn in Rhode Island demonstrating
severe venous pathology, including cases of phlegmasia
and loss of limb in extremities that served as donors for
superficial femoral-popliteal veins. What do you think can
explain these adverse results? Is there anything important
about the extent of the vein procurement, proximally,
close to the profunda femoral vein, or distally, down into
the popliteal-tibial veins? 
I enjoyed reading this manuscript. This is an impor-
tant work. I want to thank the Society for the privilege of
discussing it.
Dr Joe Wells. Thank you, Dr Schanzer. With regard to
the specific situations in which we would not use this vein as
a conduit: Certainly, if a patient had preexisting venous
insufficiency and specifically significant reflux in the popliteal
or tibial system, we would refrain from using the vein. 
Regarding your second question about the extent of
vein that we used in our patients and whether this could
explain our results compared with those adverse results in
other series, we used full lengths of the superficial femoral
and popliteal vein, often behind and even below the knee,
and really saw no difference in our clinical outcome with
regard to the length of vein used. 
Dr Martin I. Schulman (Great Neck, NY). When we
reported deep vein femoral-popliteal bypasses in the mid-
1980s, the lack of morbidity was questioned. Ironically, if
these grafts had not been used in complex aortic problems,
our findings relating to their function and expendability
would remain unbelieved, unconfirmed, and essentially lost.
If until very recently a question about the qualifying exam-
ination in vascular surgery dealt with the late sequelae of
resecting major thigh and knee veins, to answer that there is
no morbidity beyond occasional benign swelling would
have been considered incorrect. We now know removing
these veins is safe, and they are valuable spare parts. 
My only problem with this excellent presentation is
labeling swelling a venous complication, because I believe
it is lymphedema and caused by lymphatic disruption dur-
ing graft harvest. That said, I think we would all agree the
real bottom line here is: What happens to the legs? 
At this point, I know it is customary to ask a question,
but I am going to answer one. I have examined 16 limbs,
seven of which were also asaphenous, more than 10 years
after superficial femoral-popliteal vein resection. One
patient who initially had a painful varicose ulcer caused by
arterial insufficiency has had a recurrence. There were no
other ulcers or stasis changes. The ankle circumference
increase in operated vs control limbs was 2.75 cm at 1
month, 0.97 cm at 1 year, and 0.48 cm at 10 years. So, let
me reassure you, Dr Wells, there are no late disasters on
the horizon. Thank you. 
Dr Wells. Thank you, Dr Schulman. 
Dr D. Eugene Strandness, Jr (Seattle, Wash). I agree
with the previous assessors that this is an outstanding
study to which we should pay attention. I have been inter-
ested in this problem for a long time, and it always
appeared to me that perhaps sacrificing this vein was real-
ly not too serious, but I am glad now that we have objec-
tive confirmation of outcome. 
There are basically only two major things that can hap-
pen to the venous system, and they are venous obstruction
to permanently block venous outflow and venous obstruc-
tion to interfere with valvular competence. They can either
occur singly or in combination. Fortunately for us, the
authors took time to look at both of these issues with a
variety of methods, which should satisfy the skeptics. In
addition, they did point out that the early studies included
examination of the incidence of deep venous thrombosis in
this cohort of patients, which I think is very important. 
What did they learn and tell us that is of importance?
First, there was evidence from the outflow and venous pres-
sure measurements of venous obstruction. In a sense,
because this vein was sacrificed, that is an oxymoron. But, in
fact, these findings are very interesting because they point
out that the extent of venous obstruction produced by this
operation did not appear to have a major impact on symp-
toms or the development of the post-thrombotic syndrome. 
Second, they showed us that valvular incompetence in
the popliteal and tibial veins was unusual, and I think this
is a critically important observation that fits my bias about
the venous system and how it operates. If the popliteal vein
and the tibioperoneal veins remain patent and competent,
the calf muscle pump will be able to function nearly nor-
mally, and that should be the case in a situation like this. 
Also, segmental venous obstruction alone at this level
appears to be benign. Of course, one cannot say the same
thing for other venous segments in the limb, and I think
that is very important. 
I would like the authors to comment on the length of
vein that was removed. I am a little bit concerned, only in
the sense that I think if you take this vein all the way down
beyond the popliteal, I cannot imagine you getting by
without trouble. After all, you are cutting off all the major
collaterals. I think that is an important point, and I would
like you to comment on how far you really did go in
removal of some of these venous segments. 
Finally, because the development of venous thrombo-
sis in a patient after such a procedure could result and be
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a catastrophe, could you tell us what kind of methods you
are using for prophylaxis against the development of deep
venous thrombosis after this procedure? 
I enjoyed the opportunity of discussing this fine study.
Thank you very much. 
Dr Wells. Thank you, Dr Strandness. Again, we used a
significant length of superficial femoral and popliteal vein,
often to a behind or below-the-knee segment. And when
we looked at our clinical outcomes with regard to the
length of vein taken, we did not see any worse outcome in
those patients who had longer segments of vein used. 
With regard to deep venous thrombosis prophylaxis,
we used low-dose subcutaneous heparin and pneumatic
compression devices perioperatively. 
Dr Mark R. Nehler (Denver, Colo). Does this data have
implications on how we should treat trauma patients? Should
we not spend the time trying to repair the popliteal vein?
Because I believe, having just taken my boards, that that was
something I was considering doing if asked that question. 
Second, why is it that the orthopedic surgeons, when
they do not operate on the veins and just operate on the
knee or the hip, cause all kinds of horrible venous trouble,
and yet you can resect huge segments of them and appar-
ently nothing happens? 
Dr Wells. Our study did not specifically look at trauma.
I would be hesitant to extrapolate any of our work to a
trauma situation, given the prolonged ischemia and soft
tissue injuries present in these patients. 
Dr Robert B. Rutherford (Silverthorne, Colo). My
question has to do with the length of follow-up. You men-
tion a mean follow-up of almost 3 years. Was there any rela-
tionship between the outcome and the length of follow-up?
You have shown continued venous hypertension and physi-
ologic obstruction, and I worry, ultimately, about the pos-
sibility of breakdown of distal valves because of chronic dila-
tion. If you have not seen that, I hope you will follow your
cases longer and report again on the long-term status of the
distal valves in reflux. However, I would like to ask if you
have any correlation in your length of follow-up with the
outcome. 
Dr Wells. Thank you. We did not see any deterioration
in clinical status or physiologic parameters when we stud-
ied these patients, but we certainly agree with you that
they warrant continued close observation. 
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